Skip to content

The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation

The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation: a Randomized Controlled Trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07442396
Enrollment
50
Registered
2026-03-02
Start date
2026-03-01
Completion date
2026-07-10
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction, Premature Ejaculation

Brief summary

The aim is to investigate the effectiveness of exercise in the treatment of erectile dysfunction and premature ejaculation.

Detailed description

The study was designed as a randomized controlled trial. Participants were divided into two equal groups: a control group and an exercise group. Patients in the control group were followed with normal conventional medical treatment, while participants in the exercise group underwent an 8-week, 3-day-a-week exercise program. All participants were evaluated before and after treatment using the Index of Erectile Function, the World Health Organization Quality of Life Short Form, and the Premature Ejaculation Diagnostic Tool.

Interventions

OTHERcontrol

Patients in the control group will be followed with normal conventional medical treatment.

OTHERexercise

Participants in the exercise group will undergo an 8-week, 3-day-a-week exercise program.

Sponsors

Uskudar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
25 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Male individuals aged 25-45 years * Individuals diagnosed with erectile dysfunction and premature ejaculation * Individuals who voluntarily agree to participate in the study and sign the informed consent form * Individuals who have the physical and cognitive capacity to participate in pelvic floor physiotherapy applications

Exclusion criteria

* Individuals with a history of surgery in the pelvic region * Individuals with a diagnosis of neurological disease or neurological disorder that may affect pelvic floor muscle function * Presence of active infection, inflammation, or painful pathology in the pelvic region * Individuals who regularly use medications that significantly affect sexual function * Individuals with serious psychiatric illness or cognitive impairment that may hinder study compliance

Design outcomes

Primary

MeasureTime frameDescription
International Index of Erectile Dysfunction10 weeksMean change in International Index of Erectile Dysfunction scores. There are five specific areas addressed including Erectile Function (questions:1-5 \& 15;score range: 0-5, maximum score:30); Orgasmic Function (questions:9-10; score range:0-5; maximum score:10); Sexual desire (questions:11-12; score range:1-5; maximum score:10); Intercourse satisfaction (questions:6-8; score range:0-5; maximum score:15); Overall satisfaction (questions:13-14; score range:1-5; maximum score:10). The lower the score represents greater dysfunction within each domain.
Premature Ejaculation Diagnostic Tool10 weeksit was developed by Symonds et al. (2007) to better define premature ejaculation for use in clinical studies, this is a 5-point Likert-type scale consisting of 5 items. The scale was adapted to Turkish by Serefoglu et al. (2009). The highest score that can be obtained from the scale is 20.0 and the lowest score is 0.0. Scores higher than 11 are defined as "Premature Ejaculation", scores of 9-10 are defined as "possible Premature Ejaculation", and scores of eight or less are defined as "no Premature Ejaculation".

Countries

Turkey (Türkiye)

Contacts

CONTACTÖmer ŞEVGİN
omer.sevgin@uskudar.edu.tr+905069787535
STUDY_CHAIRParsa Keihani

Uskudar University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026